A medically guided consultation path for clients interested in GLP-1 and GLP-1/GIP medication options. Alia helps you understand whether treatment is appropriate, what labwork is needed, and how a plan can support appetite regulation, consistency, and long-term weight goals.
GLP-1 and GLP-1/GIP medications are associated with appetite regulation, increased satiety, and improved consistency with reduced caloric intake. The right plan starts with a real medical screen, not a one-size-fits-all prescription.
Alia's process includes lab review and a medical-director visit so treatment decisions are made with health history and safety in view.
The live Alia program notes that the medications used are not compounded and are made in the US as lyophilized products requiring reconstitution.
Alia's Weight Loss service is built for clients who want structured support around body goals, appetite, metabolic health, and follow-through. The program begins with consultation and medical review so the recommendation can account for current health, labwork, goals, and whether medication is the right tool.
When appropriate, GLP-1 and GLP-1/GIP medication options may help regulate appetite, increase satiety, and support healthier long-term behavior around food. The goal is a sustainable plan that feels medically considered, not rushed.
Medication options may help reduce hunger signals and support a more manageable calorie deficit.
Many clients seek GLP-1 support because feeling full sooner can make consistency easier.
The plan may support fat reduction goals when paired with appropriate nutrition, movement, and follow-up.
Labwork and medical review help determine whether the program makes sense for your current health picture.
A guided process helps clarify dose, timing, expectations, and when to adjust the plan.
The goal is not a quick trend. It is a plan you can understand, follow, and evaluate over time.
For clients who want help reducing weight with medical guidance and a structured plan.
For clients who feel hunger, cravings, or inconsistent satiety are major barriers.
For clients who want their health history and labwork considered before moving forward.
For clients who want a guided path instead of trying to manage medication decisions alone.
Your first visit is a conversation about weight goals, prior attempts, current health, medication interest, and what support would feel realistic.
Alia can draw labs on site at consultation, or you may bring recent CBC, CMP, amylase, thyroid panel, and HbA1c results for review.
When appropriate, you will have a telehealth visit with medical director Nicole Haig, MD, before treatment moves forward.
If treatment is appropriate, the plan outlines medication option, expectations, follow-up, and what to monitor.
You will discuss goals, health history, medication interest, and whether labs should be drawn or reviewed.
A medical-director visit helps confirm whether medication treatment is appropriate for you.
If approved, treatment expectations, reconstitution, timing, and follow-up are explained before you begin.
The plan should be reviewed over time so progress, tolerability, and next steps stay aligned.
The best program is the one you understand: what medication is being considered, why it may fit, what labs are needed, what side effects to watch for, and how progress will be evaluated.
Start With a ConsultationWeight Loss care is more medically structured, with labwork and medication review. General wellness services can support energy, hydration, and maintenance goals.
Medication support addresses appetite and weight-management behavior. Aesthetic services address skin quality, facial balance, or visible treatment areas.
Lab review helps keep the plan grounded in safety. It also gives the medical team better context before making a recommendation.
This service is best approached as a guided process over time, not a single appointment with a fixed outcome.
The live Alia program states that these are not compounded medications. They are made in the US and are lyophilized, meaning they are produced in powder form and require reconstitution with bacteriostatic water.
Alia discusses GLP-1 agonists and GLP-1/GIP agonists as options when clinically appropriate.
Labwork is part of the safety process. Alia can draw labs on site at consultation, or you may bring recent CBC, CMP, amylase, thyroid panel, and HbA1c results for review.
Book a Weight Loss consultation to discuss your goals, health history, and whether a medication-based plan may fit.
The live Alia page notes a telehealth visit with medical director Nicole Haig, MD, as part of the process.
No. Weight Loss outcomes vary by client, medication fit, health history, nutrition, movement, consistency, and follow-up. The consultation is designed to clarify what is realistic for you.
Tell us what you are working toward, what you have tried, and what support you need. Alia will help determine whether Weight Loss care is the right next step.
Request Appointment